TLR4 and Hepatic fibrosis: During cholestasis, excessive inflammatory responses can activate the TLR4 signaling pathway, which promotes NF-κB activation to secrete more proinflammatory cytokines, like TNF-α and IL-6, to aggravate inflammatory damage and liver fibrosis.